Figure 2
From: Androgen receptor expression in metastatic adenocarcinoma in females favors a breast primary

Pancreatic carcinoma- Negative for Androgen receptors (None to <10% nuclei are immunoreactive, 100×).
From: Androgen receptor expression in metastatic adenocarcinoma in females favors a breast primary
Pancreatic carcinoma- Negative for Androgen receptors (None to <10% nuclei are immunoreactive, 100×).